| Enoxaparin versus unfractionated heparin in high-risk patients with non-ST-Segment elevation acute coronary syndromes managed with a intended early invasive strategy (SYNERGY) | Synergy Trial Investigators/ JAMA. 2004; 292: 45-54 |
| Acute Catherization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale | Gregg W. Stone et al./ Am Heart J 2004; 148: 764-75 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). | E. Antman et al/ Am Heart J 2005; 149: 217-26 |
| Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer. A Randomized Controlled Trial. | Trial Investigators/ JAMA 2005; 293(11):1338-1347 |
| Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. | Antman EM./ New England J Med 2006 Apr 6; 354(14):1477-88 |
| A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes. | Cohen M./ J Am Coll Cardiol 2006 Oct 3; 48(7): 1346-54 |
Inicio
